INBS
NASDAQ
US
Intelligent Bio Solutions Inc. - Common Stock
$2.75
▼ $-0.37
(-11.86%)
Vol 1.1M
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$9.1M
ROE
-270.0%
Margin
-330.1%
D/E
3.86
Beta
4.50
52W
$1–$7
Wall Street Consensus
7 analysts · Mar 20253
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2024 | $-5.41 | $-7.00 | $-1.59 |
| Jun 2024 | $-5.20 | $-13.40 | $-8.20 |
| Mar 2024 | $-8.87 | $-14.30 | $-5.43 |
| Dec 2023 | $-33.05 | $-20.70 | +$12.35 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $607K | $729K | $844K | $1.1M | $897K |
| Net Income | — | -$2.2M | -$2.5M | -$3.1M | -$3.0M | -$2.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -227.5% | -171.7% | -227.5% | -227.5% | -227.5% | -270.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -366.2% | -349.5% | -346.2% | -346.2% | -346.2% | -330.1% |
| Gross Margin | 39.8% | 58.8% | 40.9% | 40.9% | 40.9% | 43.1% |
| D/E Ratio | 6.58 | 6.96 | 6.58 | 6.58 | 6.58 | 3.86 |
| Current Ratio | 0.77 | 1.12 | 0.77 | 0.77 | 0.77 | 0.89 |
Key Ratios
ROA (TTM)
-118.9%
P/S (TTM)
2.78
P/B
4.0
EPS (TTM)
$-12.81
CF/Share
$-7.57
Rev Growth 3Y
+91.1%
52W High
$7.25
52W Low
$0.54
$0.54
52-Week Range
$7.25
Financial Health
Free Cash Flow
-$1.6M
Net Debt
$1.2M
Cash
$740K
Total Debt
$1.9M
As of Dec 31, 2025
How does INBS compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
INBS valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
2.8
▲
8%
above
peers
(2.6)
vs Peers
vs Industry
Fair value
P/B ratio
4.0
▲
43%
above
peers
(2.8)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
INBS profitability vs Health Care peers
ROE
-270.0%
▼
601%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-330.1%
▼
1237%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Gross margin
43.1%
▼
19%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
-118.9%
▼
460%
below
peers
(-21.2%)
vs Peers
vs Industry
Weak
INBS financial health vs Health Care peers
D/E ratio
3.9
▼
80%
below
peers
(19.3)
vs Peers
vs Industry
Above avg
Current ratio
0.9
▼
59%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
4.5
▲
329%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
INBS fundamentals radar
INBS
Peer median
Industry
INBS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
INBS vs peers: key metrics
Latest News
No related news yet